Debate: Intermediate-Risk Pulmonary Embolism – Catheter-directed Thrombolysis as the Primary Option
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Bristol-Myers Squibb; Janssen; Bayer AG; Portola Pharmaceuticals; BTG
- Consultant Fee/Honoraria/Speaker's Bureau - Pfizer